Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-15 Purchase | 2021-06-17 7:15 pm | PDS Biotechnology Corp | PDSB | Glover Steve C Director | 5,882 | $8.5 | $49,997 | 72,790 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-05-24 Option Award | 2024-07-18 9:35 pm | N/A 2033-05-24 | ZyVersa Therapeutics Inc. | ZVSA | Glover Stephen C. Chief Executive Officer | 1,627 | $0 | 1,627 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-25 4:05 pm | N/A 2034-06-24 | PDS Biotechnology Corp | PDSB | Glover Stephen C. Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2024-03-07 Disposition | 2024-03-07 5:45 pm | N/A N/A | Ambrx Biopharma Inc. | AMAM | Glover Stephen C. Director | 50,356 | $0 | 0 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-17 5:26 pm | N/A 2033-07-14 | PDS Biotechnology Corp | PDSB | Glover Stephen C. Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2023-06-07 Option Award | 2023-06-09 4:17 pm | N/A 2033-06-07 | Ambrx Biopharma Inc. | AMAM | Glover Stephen C. Director | 142,500 | $0 | 142,500 (Direct) | View |
| 2023-05-18 Option Award | 2023-05-26 8:20 pm | N/A 2033-05-18 | Ambrx Biopharma Inc. | AMAM | Glover Stephen C. Director | 210,000 | $0 | 210,000 (Direct) | View |
| 2022-12-12 Option Award | 2022-12-14 7:24 pm | 2022-12-12 N/A | ZyVersa Therapeutics Inc. | ZVSA | Glover Stephen C. Chief Executive Officer | 1,499,542 | $0 | 1,366,196 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-29 4:16 pm | N/A 2032-06-28 | PDS Biotechnology Corp | PDSB | Glover Steve C Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-17 7:15 pm | N/A 2031-06-17 | PDS Biotechnology Corp | PDSB | Glover Steve C Director | 9,000 | $0 | 72,790 (Direct) | View |
| 2020-06-23 Option Award | 2020-06-25 6:57 pm | N/A 2030-06-23 | PDS Biotechnology Corp | PDSB | Glover Steve C Director | 9,000 | $0 | 9,000 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:30 pm | N/A N/A | PDS Biotechnology Corp | PDSB | Glover Steve C Director | 38,400 | $1.3 | 57,908 (Direct) | View |